Dear Editor, Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are a novel class of drugs that have emerged in the treatment of patients with type 2 diabetes mellitus and obesity
Heres what you need to know: What Are GLP-1 Medications
A number of other manufacturers are developing dual- and tri-agonists (e.g., Amgen, Carmot, Zealand), setting the stage for a competitive market
Any laboratory work using the blend has to account for that asymmetry rather than treating the vial as a single 80mg unit
Its also suitable for a wider range of body areas and appeals to clients who want a smoother, more sculpted look without turning to surgery or liposuction
Novo had a first-to-market advantage with injectables, but initially struggled to meet explosive demand